Dr. Erin Yim, MD

Dr. Yim practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Yim's NPI, 1396326062, was assigned on April 15, 2021. Dr. Yim graduated from Loma Linda University School Of Medicine in 2021. Dr. Yim's California license number on file is A192378.

Dr. Yim's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Yim's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Yim is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Yim to 1 more hospital, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yim practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Yim's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Yim is board certified in internal medicine by the American Board of Internal Medicine. Dr. Yim has a license on file in California.

CMS data shows 25 Medicare services from Dr. Yim across 1 procedure code in 2024, for 33 Medicare patients. Medicare paid $3,526 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Yim in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 39% are also on Medicaid. Their average risk score is 3.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yim's median patient age at 63, with 56% women.

In 2024, Dr. Yim wrote 159 Medicare Part D claims for 32 patients. 74% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $213 in total drug cost. In 2023, CMS named 128 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Yim for performance year 2024, reported as part of a group. Dr. Yim accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Yim from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $100.

Dr. Yim graduated from Loma Linda University School Of Medicine in 2021.

Dr. Yim is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.